Particularly, TAMs induce STAT3 pathway regulating the expression of stemness genes, via NF-kappa-B activation, in CSCs in different malignancies including breast cancer, liver cancer, prostate cancer, pancreatic cancer and colon cancer (139, 209–213). The gene discussed is STAT3; the disease is breast carcinoma.